Related Experiment Videos
Research and development of antibacterial agents
1Antimicrobial Research Centre Department of Microbiology, University of Leeds, Leeds LS2 9JT UK. I.Chopra@leeds.ac.uk.
Current Opinion in Microbiology
|March 6, 1999
Summary
New antibacterial drugs face resistance due to structural similarities to existing ones. Novel drug discovery targeting new molecular mechanisms is crucial to combat rising bacterial resistance effectively.
Area of Science:
- Microbiology and Infectious Diseases
- Drug Discovery and Development
- Antimicrobial Resistance
Background:
- The rise of bacterial resistance to current antibiotics necessitates the development of novel therapeutic agents.
- Existing antibiotic classes are facing widespread resistance, limiting treatment options.
Purpose of the Study:
- To evaluate the potential for bacterial resistance to newly developed antibacterial agents.
- To propose strategies for discovering novel antibiotics that minimize the emergence of resistance.
Main Methods:
- Analysis of new antibacterial agents, including those inhibiting macromolecular synthesis and bacterial membrane function.
- Assessment of structural similarities between new agents and existing antibiotic classes.
- Review of research strategies for novel antibiotic discovery.
Main Results:
- Many new antibacterial agents are analogues of older classes, suggesting existing resistance mechanisms may adapt.
- Oxazolidinones and cationic peptides represent exceptions with potentially novel mechanisms.
- Structurally novel drugs targeting new molecular targets are less likely to encounter pre-existing resistance.
Conclusions:
- Development of new antibacterial agents requires careful consideration of potential resistance mechanisms.
- Prioritizing structurally novel compounds and new molecular targets is essential for long-term efficacy.
- Future research should focus on innovative strategies to overcome and prevent antimicrobial resistance.